LOX and gastric cancer: The meta-analysis outcomes demonstrated that LOX expression was not related to gender (OR = 0.96, 95% CI = 0.652–1.415, p = 0.836), Lauren classification (OR = 0.943, 95% CI = 0.710–1.252, p = 0.686), differentiation (OR = 0.981, 95% CI = 0.702–1.373, p = 0.912), and depth of invasion (OR = 1.362, 95% CI = 0.232–8.013, p = 0.733) in patients with GC.